Advertisement

Topics

MVM Life Science Partners LLP Company Profile

18:30 EDT 24th June 2018 | BioPortfolio

MVM creates, finances and builds life science companies that develop world-class technology with a clear focus on products for major markets. MVM manages the UK Medical Ventures Fund and the MVM International Life Sciences Fund. The funds enjoy a close relationship with and rights to technology owned by the Medical Research Council.Our investment team has extensive experience in starting, financing and growing life science companies.Team members have been responsible for creating, managing, and operating a large number of successful technology companies both in Europe and the United States.Our role does not stop after we have made an investment. The MVM team continues to work closely with scientists, academic institutions, entrepreneurs and managers to create businesses that optimise the commercial potential of their technologies.

Location

6 Henrietta Street
London
London
WC2E 8PU
United Kingdom

Contact

Phone: 44 (0) 20 7557 7500
Fax: 44 (0) 20 7557 7501
Email: thomascasdagli@mvfund.com


News Articles [1964 Associated News Articles listed on BioPortfolio]

Accelerator Life Science Partners launches new company to develop novel therapy for seizure disorders

Accelerator Life Science Partners (Accelerator), a leading life science investment and management firm, today announced that it has launched Proniras Corporation, a company developing tezampanel for t...

Chris Nave, Brandon Capital Partners: Passionate about turning innovative science into improved medical outcomes

In this interview filmed at Ausbiotech in Brisbane, Fintan Walton talks to Chris Nave, Managing Director, Brandon Capital Partners. Brandon Capital Partners makes seed and venture capital investments ...

MedCity: Your front door to the life sciences sector of London & England's greater south east

MedCity is a collaboration between the Mayor of London and the capital’s three Academic Health Science Centres - Imperial College Academic Health Science Centre, King’s Health Partners, and UCL Pa...

5 Real-Life Technologies where Biotech Meets Science Fiction

From genetic engineering to synthetic food and immortality, biotech is getting surprisingly close to recreating science fiction in real life.   Science fiction is always a step ahead of real-life sci...

IQVIA partners with Box

Will work on managing content for the life science industry

Nearly half of life science professionals using AI - survey

Nearly half of life science professionals are using or experimenting with artificial intelligence (AI), according to a survey. Findings from the surveys in two webinars involving 374 senior pharma an...

California Life Science Sector Workforce Trends Report: Amgen, Pfizer and Genentech Leading Emplo...

The Biocom Institute and California Life Sciences Institute (CLSI) released their third biennial life science industry report. Overall, the report paints a very positive picture of the life science in...

Pivotal Partners China Closes $150 Million Fund to Incubate New Companies

Pivotal bioVenture Partners China, a new early-stage VC funded by Nan Fung Life Sciences, closed its first fund with $150 million. The firm plans to incubate life science companies in China by in-lice...

PubMed Articles [2518 Associated PubMed Articles listed on BioPortfolio]

My partner's stories: relationships between personal and vicarious life stories within romantic couples.

In this paper, we examined relationships and differences between personal and vicarious life stories, i.e., the life stories one knows of others. Personal and vicarious life stories of both members of...

Quality of Life in Partners of Young and Old Breast Cancer Survivors.

Partners of breast cancer survivors experience the effects of a spouse's cancer years after treatment. Partners of younger survivors (YPs) may experience greater problems than partners of older surviv...

Evaluating a psychosocial intervention for men with prostate cancer and their partners: Outcomes and lessons learned from a randomized controlled trial.

This study evaluated the process and outcome of a psychosocial intervention for men with prostate cancer and their partners. As more men survive prostate cancer, they and their partners need help and ...

Silkworm: A Promising Model Organism in Life Science.

As an important economic insect, silkworm Bombyx mori (L.) (Lepidoptera: Bombycidae) has numerous advantages in life science, such as low breeding cost, large progeny size, short generation time, and ...

Stronger social bonds do not always predict greater longevity in a gregarious primate.

In group-living species, individuals often have preferred affiliative social partners, with whom ties or bonds can confer advantages that correspond with greater fitness. For example, in adult female ...

Clinical Trials [2402 Associated Clinical Trials listed on BioPortfolio]

Improving STEM Outcomes for Young Children With Language Learning Disabilities

The sophisticated language of science can be a barrier to Science, Technology, Engineering, and Math (STEM) learning, especially for children who have specific language impairment (SLI). T...

Six Months Evaluation of Next Science Acne Creams on Facial Acne in Adult Females.

To assess facial acne vulgaris clinical and psychological outcomes by measuring differences in lesions counts, investigator global assessment, and subjects quality of life scores over 6 mo...

Acceptance and Commitment Therapy in Improving Well-Being in Patients With Stage III-IV Cancer and Their Partners

This pilot clinical trial studies how well acceptance and commitment therapy works in improving well-being in patients with stage III-IV cancer and their partners. Learning how to accept n...

Partners Demonstration Project of PrEP and ART

The purpose of this protocol is to determine user preferences for antiretroviral therapy (ART) for HIV-1 infected partners and pre-exposure prophylaxis (PrEP) HIV-1 un-infected partners an...

Helping African American Prostate Cancer Survivors and Their Partners Cope With Challenges After Surgery for Prostate Cancer

RATIONALE: Telephone counseling after radical prostatectomy may help African American prostate cancer survivors and their intimate partners cope with the problems and challenges of surgery...

Companies [3193 Associated Companies listed on BioPortfolio]

Life Science Washington

What: Hosted by Life Science Washington, the inaugural East-West Life Science Summit will showcase life science research, discovery, entrepreneurship, and innovation throughout Ea...

Fountain Healthcare Partners

Fountain Healthcare Partners is a life science venture capital fund with offices in Dublin, and New York. Founded in 2008, Fountain is Ireland’s largest dedicated life scienc...

H.I.G. BioHealth Partners

H.I.G. BioHealth Partners is the dedicated life-science investment affiliate of H.I.G. Capital. H.I.G. BioHealth Partners invests in a broad range of healthcare opportunities acro...

Nanostim, Inc.

Nanostim, an early-stage medical device start-up company based in Milpitas, Calif., is also backed by InterWest Partners, US Venture Partners, Emergent Medical Partners and Life S...

Arysta LifeScience

Headquartered in Tokyo, Japan, Arysta LifeScience is the world’s largest privately held crop protection and life science company with 2009 revenues of JPY112 billion (US$1.2 ...

More Information about "MVM Life Science Partners LLP" on BioPortfolio

We have published hundreds of MVM Life Science Partners LLP news stories on BioPortfolio along with dozens of MVM Life Science Partners LLP Clinical Trials and PubMed Articles about MVM Life Science Partners LLP for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of MVM Life Science Partners LLP Companies in our database. You can also find out about relevant MVM Life Science Partners LLP Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record